Jazz Pharmaceuticals PLC
JAZZ: XNAS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$285.00 | Ttxl | Pmrxbncz |
Placing Jazz Pharmaceuticals Under Review
We are placing Jazz under review as we evaluate analyst stock coverage decisions. As a reminder, we provide broad coverage of more than 1,500 companies globally and periodically adjust our coverage according to investor interest and staffing.